T/LHYH 0001-2022 Active Group standards

T/LHYH 0001-2022 Modern Pharmaceutical Industry Competition Compliance Guideline

Publish Date: 2022-07-01 Implement Date: 2022-08-20 For services related to genuine standard inquiry, procurement, translation, and other related services in China, please Contact Us

Price: $ 20.00

Out of stock

Basic Information

Standard Code: T/LHYH 0001-2022

Standard Type: Group standards

Standard Status: Active

is_force_gb: no

CCS Name: -

ICS Name: Integrated services

Publish Date: 2022-07-01

Implement Date: 2022-08-20

Scope

Scope: This document applies to the anti-monopoly competition compliance management of the modern pharmaceutical industry in Linhai City, aiming to prevent and reduce the risk of anti-monopoly violations. Enterprises engaged in the production of APIs and pharmaceutical excipients, such as those requiring upstream chemical raw materials and pharmaceutical intermediates, may refer to and use this document for reference. Main technical content: This document stipulates the basic requirements for the modern pharmaceutical industry to participate in market competition in accordance with anti-monopoly regulations, covering guidance on organization and personnel, risk identification, risk prevention, risk assessment and disposal, establishment of a competition compliance management system, and the responsibilities of industry associations. This document applies to the anti-monopoly competition compliance management of the modern pharmaceutical industry in Linhai City, aiming to prevent and reduce the risk of anti-monopoly violations. Enterprises engaged in the production of APIs and pharmaceutical excipients, such as those requiring upstream chemical raw materials and pharmaceutical intermediates, may refer to and use this document for reference.